U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950437) titled 'pBFS Guided aiTBS Over Language Network for ASD Child' on March 10.
Brief Summary: The aim of this trial is to evaluate the efficacy and safety of precision neuromodulation in improving language ability in children with autism spectrum disorder (ASD) who also have language development delay. The neuromodulation will be delivered using the accelerated intermittent theta burst stimulation (aiTBS) protocol, targeting the language network in the left superior frontal gyrus (SFG), guided by personalized Brain Functional Sector (pBFS) technology.
Study Start Date: April 25
Study Type: INTERVENTIONAL
Condition:
Autism Spectrum Disorder W...